In 2020, drug makers Dr Reddy's Laboratories and Lupin had also reported cyber security breaches
The company, however, did not disclose the financial details of the transaction
In a warning letter, the US Food and Drug Administration (USFDA) pointed out various lapses at the Halol plant which produces finished pharmaceutical products
As per the US Food and Drug Administration's Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling lots of Diltiazem Hydrochloride extended-release capsules which are used to treat angina, high...
The upfront payment of $8 per share of common stock in cash represents a premium of around 33 per cent to Concert’s 30-day volume weighted average price as of January 18, 2023
As per the enforcement report by the US health regulator, the US-based arm of Dr Reddy's Laboratories is recalling over 48,000 cartons of a drug used to treat sneezing, runny or stuffy nose.
Total revenue from operations stood at Rs 11,241 crore in the period under review
The Mumbai-based drug maker has inked a pact with Sun Pharma Advanced Research Company (SPARC) to commercialise benzyl alcohol and propylene glycol-free phenobarbital sodium powder for injection in the US
A recent Supreme Court ruling in a pending BCCI plea has paved the way for Sourav Ganguly and Jay Shah to continue as BCCI president and secretary...
The Mumbai-based company had posted a net profit of Rs 1,444 crore in April-June 2021-22
A US-based unit of Sun Pharma is recalling 50,680 vials of Testosterone Cypionate Injection, used to treat low testosterone in adult males, in the American...
At 9:18 am, the 30-share BSE Sensex was trading 1,333 points or 2.46 per cent lower at 52,969, whereas the NSE Nifty 50 index declined 376 points or 2.33 per...
The Mumbai-based drug major on Monday reported a net profit of Rs 894 crore in the January-March period of 2020-21.
At 9:18 am, BSE Sensex was down 364 points or 0.65 per cent at 55,561, whereas the Nifty 50 index slipped 91 points or 0.55 per cent at 16,569.
The 30-share BSE benchmark settled 105.82 points or 0.19 per cent lower at 54,364.85. During the day, it hit a high of 54,857.02 and a low of 54,226.33.
The US Food and Drug Administration conducted a Good Manufacturing Practices (GMP) inspection of the Halol facility from April 26 to May 9, 2022, the...
The Sensex rose 33 points to close at 55,702 and Nifty 50 index advanced 5 points to close at 16,682.
While Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Pharma is recalling a...
The Mumbai-based company's product is the generic version of Viatris Specialty LLC's Revatio
The Mumbai-based drug major had reported a consolidated net profit of Rs 1,852.4 crore in the October-December period of the previous fiscal.
Sun Pharma is recalling 696 bottles of Pregabalin capsules (50 mg), used for the treatment of epilepsy, anxiety, and nerve pain, in the US market.
On Wednesday, Sensex shed 329.06 points as it closed 0.57 per cent lower at 57,788.03. The Nifty 50 closed 10.3.50 points or 0.6 per cent lower at 17,221.40.
The 30-share index was trading 400.87 points or 0.67 per cent higher at 60,320.56 in initial deals. Nifty rose 120.10 points or 0.67 per cent to 17,993.70.
Sensex fell 10.6 per cent or 126.35 points on Monday hitting IndusInd bank the worst.
Foreign institutional investors (FIIs) turned net buyers in the capital market, as they purchased shares worth Rs 244.87 crore on Tuesday.
